Ritonavir interacts with bortezomib to enhance protein ubiquitination and histone acetylation synergistically in renal cancer cells

Urology

Volumn 79, Issue 4, 2012, Pages 966.e13-966.e21

  Sato, Akinori ^a   Asano, Takako ^a   Ito, Keiichi ^a   Asano, Tomohiko ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; HISTONE DEACETYLASE; LIPOCORTIN 5; RITONAVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; COLONY FORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG TOLERABILITY; ENDOPLASMIC RETICULUM STRESS; HISTONE ACETYLATION; IN VIVO STUDY; KIDNEY CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UBIQUITINATION; WESTERN BLOTTING;

EID: 84859436008     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.11.033     Document Type: Article

References (25)

1. M.J. Ratain, T. Eisen, W.M. Stadler Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma J Clin Oncol 24 2006 2505 2512 (Pubitemid 46630627)
2. B. Escudier, T. Eisen, W.M. Stadler Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 2007 125 134 (Pubitemid 46089673)
3. R.J. Motzer, B. Escudier, S. Oudard Phase 3 trial of everolimus for metastatic renal cell carcinoma: Final results and analysis of prognostic factors Cancer 116 2010 4256 4265
4. C. Naujokat, S. Hoffmann Role and function of the 26S proteasome in proliferation and apoptosis Lab Invest 82 2002 965 980
5. E.G. Mimnaugh, W. Xu, M. Vos Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity Mol Cancer Ther 3 2009 551 566 (Pubitemid 39193734)
6. C. Naujokat, O. Sezer, H. Zinke Proteasome inhibitors induced caspase-dependent apoptosis and accumulation of p21WAF1/Cip1 in human immature leukemic cells Eur J Haematol 65 2000 221 236
7. I. Zavrski, C. Naujokat, K. Niemller Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletion J Cancer Res Clin Oncol 129 2003 383 391 (Pubitemid 36995137)
8. G.V. Kondagunta, B. Drucker, L. Schwartz Phase II trial of bortezomib for patients with advanced renal cell carcinoma J Clin Oncol 22 2004 3720 3725 (Pubitemid 41095212)
9. M. Kraus, E. Malenke, J. Gogel Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis Mol Cancer Ther 7 2008 1940 1948
10. X. Wu, L. Sun, W. Zha HIV protease inhibitors induce endoplasmic reticulum stress and disrupt barrier integrity in intestinal epithelial cells Gastroenterology 138 2010 197 209
11. L.L. Vindeløv, I.J. Christensen, N.I. Nissen A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis Cytometry 3 1983 323 327 (Pubitemid 13087609)
12. P. Bali, M. Pranpat, J. Bradner Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: A novel basis for antileukemia activity of histone deacetylase inhibitors J Biol Chem 280 2005 26729 26734 (Pubitemid 41040705)
13. W. Fiskus, Y. Ren, A. Mohapatra Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: A result of hyperacetylation and inhibition of chaperone function of heat shock protein 90 Clin Cancer Res 13 2007 4882 4890 (Pubitemid 47294796)
14. P.G. Richardson, B. Barlogie, J. Berenson A phase 2 study of bortezomib in relapsed, refractory myeloma N Engl J Med 348 2003 2609 2617 (Pubitemid 36741588)
15. J.R. Berenson, S. Jagannath, B. Barlogie Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma Cancer 104 2005 2141 2148 (Pubitemid 41579960)
16. H. Kanayama, K. Tanaka, M. Aki Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells Cancer Res 51 1991 6677 6685
17. T. Hideshima, P. Richardson, D. Chauhan The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells Cancer Res 61 2001 3071 3076 (Pubitemid 32691956)
18. N. Mitsiades, C.S. Mitsiades, V. Poulaki Molecular sequelae of proteasome inhibition in human multiple myeloma cells Proc Natl Acad Sci U S A 99 2002 14374 14379 (Pubitemid 35257679)
19. M. Hinz, D. Krappmann, A. Eichten NF-kappaB function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S-phase transition Mol Cell Biol 19 1999 2690 2698 (Pubitemid 29144513)
20. L.V. Pham, A.T. Tamayo, L.C. Yoshimura Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis J Immunol 171 2003 88 95 (Pubitemid 36745276)
21. A. Srirangam, R. Mitra, M. Wang Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer Clin Cancer Res 12 2006 1883 1896
22. V.M. Richon, T.W. Sandhoff, R.A. Rifkind Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation Proc Natl Acad Sci U S A 97 2000 10014 10019
23. A. Sato, T. Asano, A. Horiguchi Combination of suberoylanilide hydroxamic acid and ritonavir is effective against renal cancer cells Urology 76 764 2010 e7 e13
24. A. Sato, T. Asano, A. Horiguchi Antitumor effect of suberoylanilide hydroxamic acid and topotecan in renal cancer cells Oncol Res 19 2011 217-213
25. A. Sato, T. Asano, K. Ito Suberoylanilide hydroxamic acid (SAHA) combined with bortezomib inhibits renal cancer growth by enhancing histone acetylation and protein ubiquitination synergistically BJU Int 2011 [Epub ahead of print]